Laurus Labs Ltd (LAURUSLABS) — Announcement | 31 August 2026

· BSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Laurus Labs to attend Antique Pharma Investor Day on September 7, 2026
💡 Investor Takeaway
Shareholders should note the company is engaging directly with investors soon.

Laurus Labs announced it will attend the Antique Pharma Investor Day in Hyderabad on September 7, 2026, as part of an investor conference. The meeting is in-person and subject to change, with no unpublished price sensitive information to be shared.

📄 View Original Announcement (PDF)

About Laurus Labs Ltd (LAURUSLABS)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹1,03,025.6 Cr P/E: 94.1 ROE: 20.6% ROCE: 20.8% Div Yield: 0.06%

View full LAURUSLABS stock details →

📡 Get AI alerts when LAURUSLABS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track LAURUSLABS — Free

📊 More LAURUSLABS filings

See all LAURUSLABS filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when LAURUSLABS files new disclosures

Track LAURUSLABS filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track LAURUSLABS — Free

Free account · 2 AI queries/day